Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Hemodialysis Patients
نویسندگان
چکیده
منابع مشابه
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Hemodialysis Patients
Background: Left ventricular hypertrophy (LVH) is a common cardiovascular complication and an independent risk factor for cardiovascular death in hemodialysis (HD) patients. Previous studies have shown that fibroblast growth factor 23 (FGF23), which has an important role in phosphate metabolism, is elevated in HD patients. Objectives: The aim of this study was to determine the association of FG...
متن کاملFibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
BACKGROUND Fibroblast growth factor 23 (FGF-23) is a phosphorus-regulating hormone. In chronic kidney disease (CKD), circulating FGF-23 levels are markedly elevated and independently associated with mortality. Left ventricular hypertrophy and coronary artery calcification are potent risk factors for mortality in CKD, and FGFs have been implicated in the pathogenesis of both myocardial hypertrop...
متن کاملHigher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients
AIMS The concentration of fibroblast growth factor 23 (FGF-23) is elevated in patients on dialysis. FGF receptors have been implicated in the pathogenesis of left ventricular (LV) hypertrophy. The objective of this study was to examine the associations between high plasma FGF-23 concentration and LV systolic dysfunction. METHODS We tested the hypothesis that high plasma FGF-23 concentration i...
متن کاملCardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients
BACKGROUND Cardiac biomarkers are often elevated in dialysis patients showing the presence of left ventricular dysfunction. The aim of the study is to establish the plasma levels of high-sensitivity cardiac troponin T (hs TnT), precursor of B-natriuretic peptide (NT-proBNP) and high sensitivity C-reactive protein (hs CRP) and their relation to the presence of left ventricular hypertrophy (LVH) ...
متن کاملElectrocardiographic Left Ventricular Hypertrophy and Outcome in Hemodialysis Patients
BACKGROUND AND AIMS Electrocardiography (ECG) is the most widely used initial screening test for the assessment of left ventricular hypertrophy (LVH), an independent predictor of cardiovascular mortality in patients with end-stage renal disease (ESRD). However, traditional ECG criteria based only on voltage to detect LVH have limited clinical utility for the detection of LVH because of their po...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Clinical Medicine
سال: 2014
ISSN: 2158-284X,2158-2882
DOI: 10.4236/ijcm.2014.517141